Waters Corporation
ACQUITY How-to-Series

The Use of LC-MS to Assess and Control the Influence of Fab Glycosylation

The Use of LC-MS to Assess and Control the Influence of Fab Glycosylation on the Pharmacological Properties of a Monoclonal Antibody presented by Bryan Harmon, Ph.D. Bioproduct Research and Development, Eli Lilly and Company, at WCBP 2018.